Literature DB >> 21710981

Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors: investigating the relationships involving stereochemistry, hydrogen bonding, and biological activity.

Katherine E Peterson1, Maris A Cinelli, Andrew E Morrell, Akhil Mehta, Thomas S Dexheimer, Keli Agama, Smitha Antony, Yves Pommier, Mark Cushman.   

Abstract

The DNA-relaxing enzyme topoisomerase I (Top1) can be inhibited by heterocyclic compounds such as indolocarbazoles and indenoisoquinolines. Carbohydrate and hydroxyl-containing side chains are essential for the biological activity of indolocarbazoles. The current study investigated how similar functionalities could be "translated" to the indenoisoquinoline system and how stereochemistry and hydrogen bonding affect biological activity. Herein is described the preparation and assay of indenoisoquinolines substituted with short-chain alcohols, diols, and carbohydrates. Several compounds (including those derived from sugars) display potent Top1 poisoning and antiproliferative activities. The Top1 poisoning activity of diol-substituted indenoisoquinolines is dependent upon stereochemistry. Although the effect is striking, molecular modeling and docking studies do not indicate any reason for the difference in activity due to similar calculated interactions between the ligand and Top1-DNA complex and ambiguity about the binding mode. A stereochemical dependence was also observed for carbohydrate-derived indenoisoquinolines. Although similar trends were observed in other classes of Top1 inhibitors, the exact nature of this effect has yet to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710981      PMCID: PMC3151643          DOI: 10.1021/jm101338z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  59 in total

1.  Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison.

Authors:  Smitha Antony; Glenda Kohlhagen; Keli Agama; Muthusamy Jayaraman; Shousong Cao; Farukh A Durrani; Youcef M Rustum; Mark Cushman; Yves Pommier
Journal:  Mol Pharmacol       Date:  2004-11-05       Impact factor: 4.436

Review 2.  Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins.

Authors:  Y Pommier
Journal:  Semin Oncol       Date:  1996-02       Impact factor: 4.929

3.  Syntheses and biological activities of rebeccamycin analogues with uncommon sugars.

Authors:  Guisheng Zhang; Jie Shen; Hao Cheng; Lizhi Zhu; Lanyan Fang; Sanzhong Luo; Mark T Muller; Gun Eui Lee; Lijun Wei; Yuguo Du; Duxin Sun; Peng George Wang
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

4.  On the binding of indeno[1,2-c]isoquinolines in the DNA-topoisomerase I cleavage complex.

Authors:  Xiangshu Xiao; Smitha Antony; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2005-05-05       Impact factor: 7.446

5.  Nitrosation of sugar oximes: preparation of 2-glycosyl-1-hydroxydiazene-2-oxides.

Authors:  Jörg Brand; Thomas Huhn; Ulrich Groth; Johannes C Jochims
Journal:  Chemistry       Date:  2005-12-23       Impact factor: 5.236

6.  Synthesis and mechanism of action studies of a series of norindenoisoquinoline topoisomerase I poisons reveal an inhibitor with a flipped orientation in the ternary DNA-enzyme-inhibitor complex as determined by X-ray crystallographic analysis.

Authors:  Alexandra Ioanoviciu; Smitha Antony; Yves Pommier; Bart L Staker; Lance Stewart; Mark Cushman
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

7.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

8.  Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase I.

Authors:  M J Luzzio; J M Besterman; D L Emerson; M G Evans; K Lackey; P L Leitner; G McIntyre; B Morton; P L Myers; M Peel
Journal:  J Med Chem       Date:  1995-02-03       Impact factor: 7.446

9.  Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.

Authors:  M E Wall; M C Wani; A W Nicholas; G Manikumar; C Tele; L Moore; A Truesdale; P Leitner; J M Besterman
Journal:  J Med Chem       Date:  1993-09-03       Impact factor: 7.446

10.  Differential interactions of camptothecin lactone and carboxylate forms with human blood components.

Authors:  Z Mi; T G Burke
Journal:  Biochemistry       Date:  1994-08-30       Impact factor: 3.162

View more
  8 in total

1.  Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.

Authors:  Daniel E Beck; Monica Abdelmalak; Wei Lv; P V Narasimha Reddy; Gabrielle S Tender; Elizaveta O'Neill; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2015-04-24       Impact factor: 7.446

2.  Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.

Authors:  Daniel E Beck; Wei Lv; Monica Abdelmalak; Caroline B Plescia; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2016-02-09       Impact factor: 3.641

3.  Identification, synthesis, and biological evaluation of metabolites of the experimental cancer treatment drugs indotecan (LMP400) and indimitecan (LMP776) and investigation of isomerically hydroxylated indenoisoquinoline analogues as topoisomerase I poisons.

Authors:  Maris A Cinelli; P V Narasimha Reddy; Peng-Cheng Lv; Jian-Hua Liang; Lian Chen; Keli Agama; Yves Pommier; Richard B van Breemen; Mark Cushman
Journal:  J Med Chem       Date:  2012-12-07       Impact factor: 7.446

4.  Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.

Authors:  Daniel E Beck; P V Narasimha Reddy; Wei Lv; Monica Abdelmalak; Gabrielle S Tender; Sophia Lopez; Keli Agama; Christophe Marchand; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2016-04-12       Impact factor: 7.446

5.  A practical and efficient approach to imidazo[1,2-a]pyridine-fused isoquinolines through the post-GBB transformation strategy.

Authors:  Taofeng Shao; Zhiming Gong; Tianyi Su; Wei Hao; Chao Che
Journal:  Beilstein J Org Chem       Date:  2017-05-04       Impact factor: 2.883

6.  Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776).

Authors:  Daniel E Beck; Keli Agama; Christophe Marchand; Adel Chergui; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2014-02-11       Impact factor: 7.446

7.  Gold(III) macrocycles: nucleotide-specific unconventional catalytic inhibitors of human topoisomerase I.

Authors:  Kate J Akerman; Alexander M Fagenson; Vidusha Cyril; Michael Taylor; Mark T Muller; Matthew P Akerman; Orde Q Munro
Journal:  J Am Chem Soc       Date:  2014-04-02       Impact factor: 15.419

8.  A robust synthesis of 7,8-didemethyl-8-hydroxy-5-deazariboflavin.

Authors:  Matthias Bender; Henrik Mouritsen; Jens Christoffers
Journal:  Beilstein J Org Chem       Date:  2016-05-06       Impact factor: 2.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.